Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The Journal of Community and Supportive Oncology|June 28, 2014
Delayed response in ipilimumab therapyAhmed Megahed, Peter Faulhaber, Tycel Phillips, et al.Cancer Research|June 17, 2005
Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirusCamilo Raggo, Rebecca Ruhl, Shane McAllister, et al.Cancer Biology & Therapy|May 21, 2014
Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkersKriti Mittal, Henry Koon, Paul Elson, et al.International Journal of Clinical Oncology|July 20, 2019
Immune checkpoint inhibitor-induced sarcoidosis-like granulomasPooja H Rambhia, Barbara Reichert, Jeffrey F Scott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinomaJared A Gollob, Korina G Veenstra, Robert A Parker, et al.Journal of Cancer Research and Clinical Oncology|April 15, 2016
Parotid melanoma of unknown primaryJeffrey F Scott, Cheryl L Thompson, Ritva Vyas, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinomaDaniel C Cho, Igor Puzanov, Meredith M Regan, et al.Cancer Research|May 11, 2011
MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agentsWeiwen Fan, Zhe Tang, Lihong Yin, et al.Journal of Translational Medicine|November 4, 2010
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trialHelen Gogas, Urania Dafni, Henry Koon, et al.Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.Pageof 2